Chrissa Schremp is Director of Business Development at Ardena. She supports biotech and pharmaceutical companies across the full development pathway, from preclinical strategy to clinical and commercial readiness.
Her experience spans drug development, analytical services, and CDMO partnerships. At Ardena, Chrissa works closely with clients to connect them with the company’s integrated service offering, including drug substance development and manufacturing, drug product formulation and manufacturing, nanomedicine solutions, bioanalysis, and CMC regulatory support. She is known for her collaborative approach and industry insight, helping support program continuity across complex therapeutic development programs.
Chrissa is based in the United States and brings broad experience supporting pharmaceutical innovators through integrated development and manufacturing strategies.
